nogalamycin and Lymphoma--Non-Hodgkin

nogalamycin has been researched along with Lymphoma--Non-Hodgkin* in 1 studies

Trials

1 trial(s) available for nogalamycin and Lymphoma--Non-Hodgkin

Article	Year
A phase II study of menogaril in low-grade non-Hodgkin's lymphoma. An NCI Canada Clinical Trials Group study. Investigational new drugs, 1991, Volume: 9, Issue:1 The NCI Canada Clinical Trials Group conducted a phase II study of menogaril given intravenously every 4 weeks in low-grade non-Hodgkin's lymphoma. Fifteen of 26 eligible patients had had no prior therapy. Partial responses were seen in 9 patients (35%). Toxicity was moderate including myelosuppression, nausea, phlebitis, alopecia, and lethargy. This drug has only modest activity in this potentially responsive group of patients. Topics: Antineoplastic Agents; Drug Evaluation; Humans; Injections, Intravenous; Lymphoma, Non-Hodgkin; Menogaril; Middle Aged; Nogalamycin	1991

Article

Year

A phase II study of menogaril in low-grade non-Hodgkin's lymphoma. An NCI Canada Clinical Trials Group study.

Investigational new drugs, 1991, Volume: 9, Issue:1

The NCI Canada Clinical Trials Group conducted a phase II study of menogaril given intravenously every 4 weeks in low-grade non-Hodgkin's lymphoma. Fifteen of 26 eligible patients had had no prior therapy. Partial responses were seen in 9 patients (35%). Toxicity was moderate including myelosuppression, nausea, phlebitis, alopecia, and lethargy. This drug has only modest activity in this potentially responsive group of patients.

Topics: Antineoplastic Agents; Drug Evaluation; Humans; Injections, Intravenous; Lymphoma, Non-Hodgkin; Menogaril; Middle Aged; Nogalamycin

1991